A detailed history of Exchange Traded Concepts, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 6,049 shares of CRL stock, worth $1.13 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,049
Previous 4,785 26.42%
Holding current value
$1.13 Million
Previous $988,000 20.55%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$187.96 - $245.29 $237,581 - $310,046
1,264 Added 26.42%
6,049 $1.19 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $97,622 - $127,109
473 Added 10.97%
4,785 $988,000
Q1 2024

Apr 15, 2024

SELL
$203.52 - $273.43 $234,455 - $314,991
-1,152 Reduced 21.08%
4,312 $1.17 Million
Q4 2023

Jan 05, 2024

SELL
$164.52 - $238.84 $290,542 - $421,791
-1,766 Reduced 24.43%
5,464 $1.29 Million
Q3 2023

Oct 18, 2023

SELL
$194.44 - $217.61 $357,769 - $400,402
-1,840 Reduced 20.29%
7,230 $1.42 Million
Q2 2023

Jul 20, 2023

BUY
$183.71 - $210.25 $352,906 - $403,890
1,921 Added 26.87%
9,070 $1.91 Million
Q1 2023

Apr 12, 2023

SELL
$191.89 - $259.92 $116,477 - $157,771
-607 Reduced 7.83%
7,149 $1.44 Million
Q4 2022

Jan 17, 2023

SELL
$197.11 - $250.07 $107,819 - $136,788
-547 Reduced 6.59%
7,756 $1.69 Million
Q3 2022

Oct 07, 2022

BUY
$182.44 - $250.54 $205,609 - $282,358
1,127 Added 15.71%
8,303 $1.63 Million
Q2 2022

Jul 20, 2022

SELL
$204.13 - $302.4 $169,019 - $250,387
-828 Reduced 10.34%
7,176 $1.54 Million
Q1 2022

Apr 26, 2022

SELL
$255.51 - $362.11 $791,825 - $1.12 Million
-3,099 Reduced 27.91%
8,004 $2.27 Million
Q4 2021

Jan 13, 2022

BUY
$351.38 - $448.68 $487,364 - $622,319
1,387 Added 14.28%
11,103 $4.18 Million
Q3 2021

Oct 18, 2021

SELL
$372.64 - $458.3 $497,101 - $611,372
-1,334 Reduced 12.07%
9,716 $4.01 Million
Q2 2021

Jul 30, 2021

SELL
$294.17 - $371.65 $57,951 - $73,215
-197 Reduced 1.75%
11,050 $4.09 Million
Q1 2021

Apr 20, 2021

BUY
$249.67 - $299.48 $958,732 - $1.15 Million
3,840 Added 51.84%
11,247 $3.26 Million
Q4 2020

Jan 19, 2021

BUY
$222.0 - $252.62 $909,312 - $1.03 Million
4,096 Added 123.71%
7,407 $1.85 Million
Q3 2020

Oct 30, 2020

BUY
$175.56 - $226.45 $209,794 - $270,607
1,195 Added 56.47%
3,311 $750,000
Q2 2020

Jul 15, 2020

BUY
$118.84 - $189.72 $128,584 - $205,277
1,082 Added 104.64%
2,116 $369,000
Q1 2020

Apr 14, 2020

BUY
$98.9 - $178.34 $37,878 - $68,304
383 Added 58.83%
1,034 $131,000
Q4 2019

Jan 22, 2020

BUY
$126.05 - $152.76 $82,058 - $99,446
651 New
651 $99,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.